COMPARATIVE SUSCEPTIBILITY PROFILE OF PIPERACILLIN TAZOBACTAM AGAINST ANAEROBIC-BACTERIA

被引:20
作者
APPELBAUM, PC
机构
[1] Department of Pathology (Clinical Microbiology), Hershey Medical Center, Hershey, PA, 17033
关键词
D O I
10.1093/jac/31.suppl_A.29
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Current data are summarized on the comparative susceptibility of Gram-positive and Gram-negative anaerobic bacteria to piperacillin/tazobactam and other anti-anaerobe agents. For β-lactamase-positive organisms, tazobactam, in fixed concentration or fixed ratio, lowered the MIC of piperacillin at least four-fold to susceptible levels in almost all cases; β-lactamase-negative strains were all susceptible to piperacillin alone. Susceptibility rates and MIC90, values for piperacillin/tazobactam were comparable to those of other anti-anaerobe agents, including other combinations of β-lactam agents with β-lactamase inhibitors, such as amoxycillin/clavulanate, ticarcillin/clavulanate, ampicillin/sulbactam and cefoperazone/sulbactam. Kinetic studies revealed IC50 and K1, values for tazobactam that were in most cases lower than those of clavulanate and sulbactam against β-lactamase-positive Gram-negative anaerobic bacilli. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 30 条
[1]   SUSCEPTIBILITIES OF 394 BACTEROIDES-FRAGILIS, NON-B-FRAGILIS GROUP BACTEROIDES SPECIES, AND FUSOBACTERIUM SPECIES TO NEWER ANTIMICROBIAL AGENTS [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1214-1218
[2]   COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES [J].
APPELBAUM, PC ;
JACOBS, MR ;
SPANGLER, SK ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :789-791
[3]   BETA-LACTAMASE PRODUCTION AND SUSCEPTIBILITIES TO AMOXICILLIN, AMOXICILLIN-CLAVULANATE, TICARCILLIN, TICARCILLIN-CLAVULANATE, CEFOXITIN, IMIPENEM, AND METRONIDAZOLE OF 320 NON-BACTEROIDES-FRAGILIS-BACTEROIDES ISOLATES AND 129 FUSOBACTERIA FROM 28 UNITED-STATES CENTERS [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) :1546-1550
[4]   CHARACTERIZATION OF BETA-LACTAMASES FROM NON-BACTEROIDES-FRAGILIS GROUP BACTEROIDES SPP BELONGING TO 7 SPECIES AND THEIR ROLE IN BETA-LACTAM RESISTANCE [J].
APPELBAUM, PC ;
PHILIPPON, A ;
JACOBS, MR ;
SPANGLER, SK ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2169-2176
[5]  
APPELBAUM PC, 1987, DIAGNOSTIC PROCEDURE, P45
[6]   SURVEY OF BACTEROIDES-FRAGILIS SUSCEPTIBILITY PATTERNS IN FRANCE [J].
BREUIL, J ;
BURNAT, C ;
PATEY, O ;
DUBLANCHET, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (01) :69-75
[7]   NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS AGAR DILUTION SUSCEPTIBILITY TESTING OF ANAEROBIC GRAM-NEGATIVE BACTERIA [J].
BROWN, WJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :385-390
[8]   INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR [J].
COLEMAN, K ;
GRIFFIN, DRJ ;
PAGE, JWJ ;
UPSHON, PA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1580-1587
[9]   COMPARATIVE ACTIVITIES OF NEWER BETA-LACTAM AGENTS AGAINST MEMBERS OF THE BACTEROIDES-FRAGILIS GROUP [J].
CUCHURAL, GJ ;
TALLY, FP ;
JACOBUS, NV ;
CLEARY, T ;
FINEGOLD, SM ;
HILL, G ;
IANNINI, P ;
OKEEFE, JP ;
PIERSON, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :479-480
[10]   COMPARATIVE INVITRO ACTIVITY OF PIPERACILLIN COMBINED WITH THE BETA-LACTAMASE INHIBITOR TAZOBACTAM (YTR-830) [J].
ELIOPOULOS, GM ;
KLIMM, K ;
FERRARO, MJ ;
JACOBY, GA ;
MOELLERING, RC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (06) :481-488